Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03054987 · ClinicalTrials.gov registry record · NA
Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT03054987 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 67 participants.
The verdict
NCT03054987, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the rates of adverse events between patients undergoing Endoscopic Ultrasound- guided biliary drainage and Endoscopic Retrograde Cholangiopancreatography for distal malignant biliary obstruction.
Interventions
- PROCEDURE ERCP
- PROCEDURE EUS-BD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03054987
The ClinicalTrials.gov registry entry for NCT03054987 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ERCP is the first listed.
NCT03054987 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03054987 about?
NCT03054987 is a clinical study titled "Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction". The purpose of this study is to compare the rates of adverse events between patients undergoing Endoscopic Ultrasound- guided biliary drainage and Endoscopic Retrograde Cholangiopancreatography for distal malignant biliary obstruction.
What is the current status of trial NCT03054987?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2016-09. Estimated completion is 2018-10.
What interventions are being tested in trial NCT03054987?
The interventions under investigation include: ERCP (PROCEDURE), EUS-BD (PROCEDURE).
Who is sponsoring clinical trial NCT03054987?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.